Compare Quest Diagnostics Inc (DGX) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs VNET Group Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while VNET Group Inc trades at $7.51 (market cap $2.14B). The key difference: Quest Diagnostics Inc is far larger — about 12.2× VNET Group Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals.
| DGX | VNET | |
|---|---|---|
Market Cap | $26.21B | $2.14B |
Sector | Health | Technology |
52-Week High | $238.50 | $14.03 |
52-Week Low | $173.49 | $6.29 |
Enterprise Value | $31.97B | $5.29B |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
